Safe Desmopressin Administration

Patent No. EP2381923 (titled "Safe Desmopressin Administration") was filed by Acerus Pharmaceuticals USA on Dec 21, 2009. The application was issued on Jun 7, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
FERRINGMay 1, 2019PRINS

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2381923

ACERUS PHARMACEUTICALS USA
Application Number
EP09796558A
Filing Date
Dec 21, 2009
Status
Patent Maintained As Amended
May 5, 2023
Publication Date
Jun 7, 2023